EIR Catalent Pharma Solutions Mar 2002

Nicholas Lyons FDA$595.00 - Available Now

FDA investigators audited the Catalent Pharma Solutions - Woodstock, IL, United States facility and issued inspectional observation (via FDA 483) on 08 Mar 2002.

Product details

  • Category:
  • Inspection end: 08 Mar 2002
  • Location: Woodstock, United States
  • FEI: 1419377
Add To Cart